-
Civica to Manufacture and Distribute Affordable Insulin
- Drastically reducing out-of-pocket costs for insulin through transformative collaboration between Civica and dedicated partners
Our Mission: Provide Quality Generic Medicines that are Available and Affordable to Everyone
- Learn about our "novel approach to doing business" in the New England
Journal of Medicine - From Fierce Healthcare: Civica CEO Ned McCoy named one of 20 Healthcare Executives to Watch
0 Million
Patients treated with Civica medications
These include:
Advocate Aurora Health
Allegheny Health Network
Aspirus Health System
Baptist Health
Baptist Health South Florida
Baylor Scott & White Health
BJC HealthCare
Christiana Care Health System
CommonSpirit Health
Cone Health
Emerson Health
Franciscan Alliance
Gary and Mary West Foundation
Griffin Hospital
Hospital Corporation of America (HCA)
Hospital Sisters Health System
Integris Health
Intermountain Healthcare
Kaiser Permanente
Kootenai Healthcare
Laura and John Arnold Foundation
Mayo Clinic
MemorialCare
Memorial Hermann
Montage Health
Memorial Sloan Kettering Cancer Center
New Hanover Regional Medical Center
NorthBay Healthcare
North Memorial Hospital
NYU Langone Health
Ochsner Health System
Peterson Center on Healthcare
Piedmont Health
Piedmont Health
ProMedica Health
Piedmont Health
Providence St. Joseph Health
Regional One Health
Reid Health
Samaritan Health Services
SCL Health
Sanford Health
SCL Health
Southeast Georgia Health System
Spectrum Health
SSM Health
St. Clair Hospital
Steward Health Care System
St. Luke's University Health Network
The Christ Hospital
ThedaCare
Trinity Health
UnityPoint Health
University of Miami Health
University of Utah Health
U.S. Department of Defense
U.S. Department of Veterans Affairs
VCU Health
Recent News
EmsanaRx Joins CivicaScript to Make Lower-Cost Generic Medicines Available to its Pharmacy Benefit Members
CivicaScript, which is dedicated to bringing lower-cost generic medicines to U.S. consumers, and EmsanaRx, PBC, the only pharmacy benefit manager built by employers, for employers, announced today that EmsanaRx is joining CivicaScript as a partnering member. The partnership will make CivicaScript medicines available to EmsanaRx’s self-funded employer members. “We welcome the partnership of EmsanaRx as...
Civica Selects Profil as Clinical Trial Partner for Affordable Insulin Initiative
Civica, Inc. announces the selection of Profil, Neuss, Germany, as its clinical trial partner to support the development of its affordable insulins. As previously announced, Civica plans to produce three insulin biosimilars – glargine, lispro and aspart – each of which will be available both in vials and prefilled pens, and sell the insulins...
Civica Announces Leadership Transition
Civica, Inc. announces that Ned McCoy, currently Civica’s Chief Operating Officer, will succeed Martin VanTrieste as Civica’s President and Chief Executive Officer, effective June 1. VanTrieste will remain an advisor to the Company and continue serving on Civica’s Board of Directors. As part of this transition, McCoy will also join the Civica Board of...
Why Civica?
Over the past two decades, shortages of generic, injectable drugs critical to the lifesaving work of hospitals in the United States have become commonplace. These drug shortages are so ubiquitous that hospitals and health care systems now maintain permanent drug shortage response teams that seek alternatives to unavailable drugs.
As a result, time that hospital pharmacists, technicians, nurses and others would prefer to spend caring for patients is spent ensuring that the patients who most need short-supply drugs get whatever supply is available.
Civica was created to reduce and prevent drug shortages and the price spikes that can accompany them. Its mission is to make quality generic medicines accessible and affordable to everyone.